Patients given EREM in clinical trials after hip replacement had significant less supplemental opioid requirement after surgery than placebo39. Furthermore, the needs for rescue medications were minimal with less instances of hypotension. Other potential advantages of EREM include no epidural catheter or pump related issues which can create gaps in analgesia postoperatively. The absence of epidural and patient controlled analgesia pump technology theoretically reduces opportunities for medication errors and pump programming errors as well. The side effects of EREM are similar to other opioids including nausea, vomiting, constipation, and respiratory depressions. Ideally, the use of EREM in a multimodal analgesic approach and with appropriate patient selection may result in analgesia without the need for any tethering pump
Patients given EREM in clinical trials after hip replacement had significant less supplemental opioid requirement after surgery than placebo39. Furthermore, the needs for rescue medications were minimal with less instances of hypotension. Other potential advantages of EREM include no epidural catheter or pump related issues which can create gaps in analgesia postoperatively. The absence of epidural and patient controlled analgesia pump technology theoretically reduces opportunities for medication errors and pump programming errors as well. The side effects of EREM are similar to other opioids including nausea, vomiting, constipation, and respiratory depressions. Ideally, the use of EREM in a multimodal analgesic approach and with appropriate patient selection may result in analgesia without the need for any tethering pump